New Clinical Trials Regulation and new IMPD-Guidelines in place

16.05.2022
Did you know that the new clinical trials regulation came into place on 31st January 2022? Please consider that you have tighter timelines (12 calendar days) to respond in case of questions.
Furthermore, the IMPD-Guidelines covering chemical and biological drug substances/drug products were updated to cover latest expectations of the regulators.

  • Avoid pitfalls and compliance gaps.
  • Learn from us how to write your IMPD successfully and how to cope efficiently with upcoming changes
  • Benefit from our long-term experience with IMPDs. 

Please feel free to contact us at info@horn-pharma.de, if you like to know more about IMPDs. 
We help you in cost-effective planning and preparation of your IMPD-documents. We know the details and guide you through the process.




Back

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail

Events

  • 10.11.2022
    Verunreinigungen in Arzneimitteln - Fokus Nitrosamine
    More
  • 15.11.2022
    MEGRA StartUp
    More
  • 18.11.2022
    Online Seminar: ATMPs: Quality and risk management
    More
Get all events



News

  • 01.09.2022
    EU-GMP Annex 1 finally published
    More
  • 26.08.2022
    New Deadlines and Chances for Nitrosamines
    More
  • 25.08.2022
    Important Aspects to consider if you use Titanium Dioxide in your Drug Products
    More
Get all news